Effects of collimator dependency and correction methods on I-123 SPECT images using x-ray-based attenuation map
暂无分享,去创建一个
[1] S. Liggett,et al. Activity of the uptake-1 norepinephrine transporter as measured by I-123 MIBG in heart failure patients with a loss-of-function polymorphism of the presynaptic α2C-adrenergic receptor , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[2] R. Jaszczak,et al. Improved SPECT quantification using compensation for scattered photons. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] E C Frey,et al. Quantitative single-photon emission computed tomography: basics and clinical considerations. , 1994, Seminars in nuclear medicine.
[4] Jan Booij,et al. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism , 2001, European Journal of Nuclear Medicine.
[5] Brad Kemp,et al. A multicenter evaluation of commercial attenuation compensation techniques in cardiac SPECT using phantom models. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[6] I G Zubal,et al. Significance of nonuniform attenuation correction in quantitative brain SPECT imaging. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] Yusuke Inoue,et al. Collimator choice in cardiac SPECT with I-123-labeled tracers , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[8] Philippe R. Franken,et al. Influence of high-energy photons on the spectrum of iodine-123 with low- and medium-energy collimators: consequences for imaging with 123I-labelled compounds in clinical practice , 1999, European Journal of Nuclear Medicine.
[9] Irène Buvat,et al. Quantitative accuracy of dopaminergic neurotransmission imaging with (123)I SPECT. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] Andrea Varrone,et al. Contribution of scatter and attenuation compensation to SPECT images of nonuniformly distributed brain activities. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] Brian F. Hutton. Cardiac single-photon emission tomography: Is attenuation correction enough? , 2004, European Journal of Nuclear Medicine.
[12] M P Sandler,et al. Image fusion using an integrated, dual-head coincidence camera with X-ray tube-based attenuation maps. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] A Pupi,et al. European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) receptor ligands. , 2002, European journal of nuclear medicine and molecular imaging.
[14] K. Ohtomo,et al. Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[15] Pierre Grangeat,et al. Absolute quantitation of iodine-123 epidepride kinetics using single-photon emission tomography: comparison with carbon-11 epidepride and positron emission tomography , 1999, European Journal of Nuclear Medicine.
[16] B. van Eck-Smit,et al. Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: a phantom study , 2005, European Journal of Nuclear Medicine and Molecular Imaging.